Academic Journal
Comparison of Remimazolam and Propofol in Large Skull Base Tumor Resections: Effects on Hemodynamic Stability, Neurocognitive Recovery, and Inflammatory Response.
| Τίτλος: | Comparison of Remimazolam and Propofol in Large Skull Base Tumor Resections: Effects on Hemodynamic Stability, Neurocognitive Recovery, and Inflammatory Response. |
|---|---|
| Συγγραφείς: | Huang L; Department of Anesthesiology, Jinan Central Hospital, Jinan, Shandong, 250013, People's Republic of China., Huang K; Operating Room, The Fourth People's Hospital of Jinan, Jinan, Shandong, 250031, People's Republic of China., Ning H; Department of Anesthesiology, Jinan Central Hospital, Jinan, Shandong, 250013, People's Republic of China., Zheng B; Department of Neurosurgery, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, Shandong, 271000, People's Republic of China. |
| Πηγή: | Drug design, development and therapy [Drug Des Devel Ther] 2026 Sep 21; Vol. 20, pp. 642884. Date of Electronic Publication: 2026 Sep 21 (Print Publication: 2026). |
| Τύπος έκδοσης: | Journal Article; Comparative Study |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: [Auckland, N.Z.] : Dove Press Limited |
| Ιατρικοί όροι (MeSH): | Propofol*/pharmacology , Propofol*/administration & dosage , Hemodynamics*/drug effects , Inflammation*/drug therapy , Skull Base Neoplasms*/surgery , Skull Base Neoplasms*/drug therapy, Cognition/drug effects ; Humans ; Female ; Male ; Retrospective Studies ; Middle Aged ; Adult ; Aged |
| Περίληψη: | Purpose: Skull base large tumor resections require precise hemodynamic control and neuroprotection. This study compared remimazolam and propofol effects on perioperative stability, postoperative neurocognitive recovery, and inflammatory responses in these patients. Methods: This retrospective study included patients who underwent large skull base tumor resections between March 2020 and February 2022. Patients were assigned to remimazolam or propofol group based on the primary anesthetic used. Hemodynamic parameters such as blood pressure, heart rate (HR), and mean arterial pressure (MAP) were recorded during the perioperative period. Serum levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) were measured preoperatively and on postoperative days 1, 3, and 7. Neurocognitive function was assessed using the Montreal Cognitive Assessment (MoCA). Results: The analysis included 257 patients (remimazolam group: n=122; propofol group: n=135). The remimazolam group showed higher systolic blood pressure at most measurement points after induction (immediately before tracheal intubation: 108.24 vs. 105.75, P=0.006), diastolic blood pressure (5 min after extubation: 78.29 vs. 74.87, P=0.005), MAP (immediately before tracheal intubation: 74.83 vs. 70.57, P=0.002), and HR (5 min after extubation: 77.14 vs. 72.93, P=0.002). Postoperative MoCA scores were higher in the remimazolam group (24 hours: 24.18 vs. 23.45, P=0.005). The remimazolam group also had lower levels of postoperative TNF-α (40.21 vs. 41.55, P=0.011) and IL-6 (63.15 vs. 65.19, P=0.013). The incidence of hypotension was lower in the remimazolam group (13.93% vs. 27.41%, P=0.008). Conclusion: For patients with large skull base tumor resections, remimazolam offers better hemodynamic stability, improved early neurocognitive recovery, and milder inflammatory responses compared to propofol. (© 2026 Huang et al.) |
| Competing Interests: | The authors have no conflicts of interest to declare. |
| References: | Neuro Oncol. 2021 Nov 2;23(11):1821-1834. (PMID: 34181733) PeerJ. 2024 Aug 26;12:e17930. (PMID: 39210920) Minerva Anestesiol. 2024 Jul-Aug;90(7-8):682-693. (PMID: 38771145) JAMA. 2017 Feb 07;317(5):516-524. (PMID: 28170483) J Anesth. 2022 Feb;36(1):152-155. (PMID: 34779923) Minerva Anestesiol. 2024 Oct;90(10):901-911. (PMID: 39101304) Age Ageing. 2024 Jul 2;53(7):. (PMID: 39058915) Medicine (Baltimore). 2023 Jul 28;102(30):e34358. (PMID: 37505153) Anaesth Crit Care Pain Med. 2024 Apr;43(2):101337. (PMID: 38061682) Front Immunol. 2023 Jan 27;14:1102312. (PMID: 36776829) BMC Anesthesiol. 2025 Mar 15;25(1):126. (PMID: 40089668) Korean J Anesthesiol. 2025 Apr;78(2):148-158. (PMID: 39844353) Cureus. 2023 Dec 11;15(12):e50312. (PMID: 38205474) BMC Anesthesiol. 2016 Mar 22;16:18. (PMID: 27001425) J Clin Anesth. 2024 May;93:111356. (PMID: 38056052) Perioper Med (Lond). 2024 Jun 14;13(1):56. (PMID: 38877533) Minerva Anestesiol. 2023 Jun;89(6):553-564. (PMID: 36852570) Laryngoscope. 2023 Feb;133(2):282-286. (PMID: 35819874) J Neurosurg Anesthesiol. 2025 Jan 01;37(1):40-46. (PMID: 38836295) Adv Ther. 2023 Oct;40(10):4395-4404. (PMID: 37490257) J Clin Med. 2024 Apr 18;13(8):. (PMID: 38673637) Neuro Oncol. 2020 Jan 11;22(1):31-45. (PMID: 31504802) J Otolaryngol Head Neck Surg. 2024 Jan-Dec;53:19160216241267737. (PMID: 39164943) J Am Geriatr Soc. 2005 Apr;53(4):695-9. (PMID: 15817019) J Clin Med. 2024 Dec 20;13(24):. (PMID: 39768714) Brain Behav. 2023 Aug;13(8):e3149. (PMID: 37431799) Int J Surg. 2024 Apr 01;110(4):2456-2457. (PMID: 38215265) Anaesthesia. 2024 Apr;79(4):410-422. (PMID: 38221513) BMC Anesthesiol. 2024 Jun 4;24(1):198. (PMID: 38834996) Front Pharmacol. 2023 Feb 06;14:1101728. (PMID: 36814492) Neurosurg Rev. 2022 Apr;45(2):1263-1273. (PMID: 34802074) Eur J Pharmacol. 2024 Feb 15;965:176276. (PMID: 38113966) Behav Brain Res. 2025 Jan 5;476:115268. (PMID: 39322063) |
| Contributed Indexing: | Keywords: early neurocognitive recovery; hemodynamic stability; postoperative inflammation; propofol; remimazolam; skull base tumor |
| Substance Nomenclature: | YI7VU623SF (Propofol) |
| Entry Date(s): | Date Created: 20260926 Date Completed: 20260926 Latest Revision: 20260928 |
| Update Code: | 20260928 |
| PubMed Central ID: | PMC13614315 |
| DOI: | 10.2147/DDDT.S642884 |
| PMID: | 42799201 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!